Bristol-Myers Squibb Company (BMY)

Basic

  • Market Cap

    $101.49B

  • EV

    $132.87B

  • Shares Out

    2,034.76M

  • Revenue

    $44.94B

  • Employees

    34,300

Margins

  • Gross

    77.01%

  • EBITDA

    40.65%

  • Operating

    18.85%

  • Pre-Tax

    19.19%

  • Net

    18.44%

  • FCF

    26.01%

Returns (5Yr Avg)

  • ROA

    5.49%

  • ROE

    13.2%

  • ROCE

    11.38%

  • ROIC

    10.22%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $64.13

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $21.51

  • Earnings (Dil)

    $3.94

  • FCF

    $5.57

  • Book Value

    $14.26

Growth (CAGR)

  • Rev 3Yr

    4.48%

  • Rev 5Yr

    15.32%

  • Rev 10Yr

    10.79%

  • Dil EPS 3Yr

    462.86%

  • Dil EPS 5Yr

    35.21%

  • Dil EPS 10Yr

    9%

  • Rev Fwd 2Yr

    -0.28%

  • EBITDA Fwd 2Yr

    -5.73%

  • EPS Fwd 2Yr

    -2.17%

  • EPS LT Growth Est

    0.22%

Dividends

  • Yield

    —

  • Payout

    57.5%

  • DPS

    $2.28

  • DPS Growth 3Yr

    8.2%

  • DPS Growth 5Yr

    7.34%

  • DPS Growth 10Yr

    5%

  • DPS Growth Fwd 2Yr

    4.65%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

22,561.0

26,145.0

42,518.0

46,385.0

46,159.0

44,935.0

Total Revenues % Chg.

8.6%

15.9%

62.6%

9.1%

-0.5%

-3.9%

Cost of Goods Sold, Total

6,410.0

7,898.0

11,773.0

9,337.0

9,781.0

10,331.0

Gross Profit

16,151.0

18,247.0

30,745.0

37,048.0

36,378.0

34,604.0

Selling General & Admin Expenses, Total

4,523.0

4,969.0

7,618.0

7,652.0

7,703.0

7,874.0

R&D Expenses

6,253.0

6,066.0

10,048.0

9,352.0

9,201.0

9,146.0

Amortization of Goodwill and Intangible Assets

97.0

1,135.0

9,688.0

10,023.0

9,595.0

9,112.0

Other Operating Expenses, Total

10,873.0

12,170.0

27,354.0

27,027.0

26,499.0

26,132.0

Operating Income

5,278.0

6,077.0

3,391.0

10,021.0

9,879.0

8,472.0

Interest Expense, Total

-152.0

-898.0

-1,381.0

-1,292.0

-1,153.0

-1,081.0

Interest And Investment Income

173.0

464.0

121.0

39.0

171.0

386.0

Net Interest Expenses

21.0

-434.0

-1,260.0

-1,253.0

-982.0

-695.0

Income (Loss) On Equity Invest.

—

-5.0

72.0

231.0

-108.0

-14.0

Currency Exchange Gains (Loss)

14.0

-13.0

23.0

21.0

96.0

60.0

Other Non Operating Income (Expenses)

1,304.0

1,496.0

1,528.0

1,708.0

1,818.0

1,991.0

EBT, Excl. Unusual Items

6,617.0

7,121.0

3,754.0

10,728.0

10,703.0

9,814.0

Restructuring Charges

-268.0

-564.0

-538.0

-187.0

-144.0

-504.0

Merger & Related Restructuring Charges

—

-1,072.0

-717.0

-831.0

-1,016.0

-567.0

Gain (Loss) On Sale Of Investments

-419.0

357.0

1,157.0

514.0

-693.0

-34.0

Gain (Loss) On Sale Of Assets

178.0

1,168.0

55.0

9.0

211.0

—

Asset Writedown

-64.0

-15.0

—

-1,155.0

-98.0

-80.0

In Process R&D Expenses

—

—

-12,533.0

-1,159.0

-815.0

-365.0

Legal Settlements

-76.0

-77.0

194.0

-82.0

-178.0

-153.0

Other Unusual Items

—

-1,943.0

1,757.0

261.0

-257.0

514.0

EBT, Incl. Unusual Items

5,968.0

4,975.0

-6,871.0

8,098.0

7,713.0

8,625.0

Income Tax Expense

1,021.0

1,515.0

2,124.0

1,084.0

1,368.0

322.0

Earnings From Continuing Operations

4,947.0

3,460.0

-8,995.0

7,014.0

6,345.0

8,303.0

Minority Interest

-27.0

-21.0

-20.0

-20.0

-18.0

-18.0

Net Income

4,920.0

3,439.0

-9,015.0

6,994.0

6,327.0

8,285.0

Net Income to Common Incl Extra Items

4,920.0

3,439.0

-9,015.0

6,994.0

6,327.0

8,285.0

Net Income to Common Excl. Extra Items

4,920.0

3,439.0

-9,015.0

6,994.0

6,327.0

8,285.0

Total Shares Outstanding

1,632.0

2,251.0

2,244.0

2,176.0

2,098.0

2,034.0

Weighted Avg. Shares Outstanding

1,633.0

1,705.0

2,258.0

2,221.0

2,130.0

2,089.5

Weighted Avg. Shares Outstanding Dil

1,637.0

1,712.0

2,258.0

2,245.0

2,146.0

2,100.3

EPS

3.0

2.0

-4.0

3.1

3.0

4.0

EPS Diluted

3.0

2.0

-4.0

3.1

3.0

3.9

EBITDA

5,868.0

7,798.0

13,824.0

20,778.0

20,161.0

18,268.0